Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

What is the DNA-dependent protein kinase, DNA-PK?

Dr Susan Lees-Miller - University of Calgary, Calgary, Canada
What is the DNA-dependent protein kinase, DNA-PK? ( Dr Susan Lees-Miller - University of Calgary, Calgary, Canada )
29 Jan 2016

DNA damage response is related to cellular homeostasis

Prof Yossi Shiloh - Tel Aviv University, Tel Aviv, Israel
DNA damage response is related to cellular homeostasis ( Prof Yossi Shiloh - Tel Aviv University, Tel Aviv, Israel )
29 Jan 2016

Checkpoint machinery protects against cancer

Prof Jiri Bartek - Danish Cancer Society Research Centre, Copenhagen, Denmark
Checkpoint machinery protects against cancer ( Prof Jiri Bartek - Danish Cancer Society Research Centre, Copenhagen, Denmark )
29 Jan 2016

Connections between DNA-PK, ATM, ATR and mTOR dependent pathways

Prof Marco Foiani - Scientific director, IFOM, Milan
Connections between DNA-PK, ATM, ATR and mTOR dependent pathways ( Prof Marco Foiani - Scientific director, IFOM, Milan )
29 Jan 2016

What is the potential of TOR inhibition for cancer therapy?

Dr Mike Hall - University of Basel, Basel, Switzerland
What is the potential of TOR inhibition for cancer therapy? ( Dr Mike Hall - University of Basel, Basel, Switzerland )
29 Jan 2016

Mathematical modelling can be used in cancer therapy

Dr Arne Lindqvist - Karolinska Institutet
Mathematical modelling can be used in cancer therapy ( Dr Arne Lindqvist - Karolinska Institutet )
29 Jan 2016

Recombination can drive tumourogenesis

Prof James Haber - Brandeis University, Waltham, USA
Recombination can drive tumourogenesis ( Prof James Haber - Brandeis University, Waltham, USA )
29 Jan 2016

The role of the PI3K and TOR pathways in cancer

Dr David Fruman - University of California, Irvine, USA
The role of the PI3K and TOR pathways in cancer ( Dr David Fruman - University of California, Irvine, USA )
29 Jan 2016

Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
22 Jan 2016

What is the link between mechanobiology and cancer?

Prof Michael Sheetz - National University of Singapore and Columbia University
What is the link between mechanobiology and cancer? ( Prof Michael Sheetz - National University of Singapore and Columbia University )
11 Jan 2016

The ManVan: a mobile cancer support service for men with prostate, testicular and penile cancer in Wales

Dr Rachel Iredale -Tenovus Cancer Care, Cardiff, Wales, UK and University of South Wales, Pontypridd, Wales, UK
The ManVan: a mobile cancer support service for men with prostate, testicular and penile cancer in Wales ( Dr Rachel Iredale -Tenovus Cancer Care, Cardiff, Wales, UK and University of South Wales, Pontypridd, Wales, UK )
11 Jan 2016

How does your garden grow? For cancer patients, small gardens could bring big benefits

Dr Ceri Phelps - University of Wales Trinity Saint David, UK
How does your garden grow? For cancer patients, small gardens could bring big benefits ( Dr Ceri Phelps - University of Wales Trinity Saint David, UK )
11 Jan 2016